SecBot SecBot
8-K ·Filed Nov 3, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed13d 17h ago SEC0001104659-26-121713
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

The authorization is discretionary with no obligation to repurchase. Monitor future 10-Q and 10-K filings for actual repurchase activity and any changes to the company's cash position or debt levels.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$68.12
T+0 close · Nov 3, 2026 · via day close
Latest settled
−5.84%
T+5 · $64.14 · next T+20 in 15d
Vs SPY
−5.26%
α at T+5
Latest observation
−6.68%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $68.12entry
  2. T+1 · 13d ago +1.25%α −0.40% · $68.97
  3. T+5 · 7d ago −5.84%α −5.26% · $64.14
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

PTC Therapeutics announced a $500 million share repurchase program authorized by its Board of Directors. The program allows management to repurchase shares through open-market transactions, privately negotiated deals, or accelerated repurchases at its discretion. No financial results or guidance were provided in this filing.

Key Facts

  • Board authorized a share repurchase program of up to $500 million of common stock
  • Repurchases may be made at management's discretion through open-market transactions, privately negotiated transactions, accelerated share repurchases, and other methods
  • The program is subject to market conditions
  • No timeline or commitment to execute any repurchases was stated
  • Market cap is $5.4 billion, making the authorization approximately 9.3% of market cap

Financial Impact

Up to $500 million share repurchase authorization, representing about 9.3% of current market cap

dilutionshare count

Risk Factors

  • Authorization does not obligate the company to repurchase any shares
  • Repurchases could reduce cash reserves available for operations or business development
  • No financial results or guidance were provided to assess the company's ability to fund the program

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-121713
Document: tmb-ex99d1.htm0001104659-26-121713
Document: 0001104659-26-121713-index-headers.html0001104659-26-121713
Document: 0001104659-26-121713-index.html0001104659-26-121713
Document: 0001104659-26-121713.txt0001104659-26-121713

Track record

29 reports on PTCT

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
  5. Nov 3, 202613d ago 8-K Neutral 3/10 Viewing Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  6. Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  7. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
  9. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
  10. Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026